Background Identification of patients at risk of deterioration is essential to guide clinical management in pulmonary arterial hype
BACKGROUND: Registry data suggest that disease progression in pulmonary arterial hypertension (PAH) ...
Background: Although pulmonary arterial hypertension (PAH) is widely accepted as deadly, if not a ra...
Several echocardiographic indices1–11 have been proposed to be prognostically important in patients ...
BACKGROUND: Identification of patients at risk of deterioration is essential to guide clinical manag...
Background Identification of patients at risk of deterioration is essential to guide clinical manage...
Pulmonary arterial hypertension is most often diagnosed in its advanced stages because of the nonspe...
textabstractObjectives: To provide a comprehensive overview of all reported cardiac magnetic resonan...
OBJECTIVES: To provide a comprehensive overview of all reported cardiac magnetic resonance (CMR) fin...
Abstract Objectives The aim of this study was to evaluate the relationships between echocardiographi...
Pulmonary arterial hypertension (PAH), defined as group 1 of the World Heart Organisation (WHO) clas...
Objectives This meta-analysis evaluates assessment of pulmonary arterial hypertension (PAH), with...
Objectives: This meta-analysis evaluates assessment of pulmonary arterial hypertension (PAH), with a...
Pulmonary arterial hypertension (PAH) is characterized by an insult in the pulmonary vasculature, wi...
BackgroundPulmonary arterial capacitance (PAC) is one of the strongest predictors of clinical outcom...
AbstractObjectivesThe aim of this study was to evaluate the relationships between echocardiographic ...
BACKGROUND: Registry data suggest that disease progression in pulmonary arterial hypertension (PAH) ...
Background: Although pulmonary arterial hypertension (PAH) is widely accepted as deadly, if not a ra...
Several echocardiographic indices1–11 have been proposed to be prognostically important in patients ...
BACKGROUND: Identification of patients at risk of deterioration is essential to guide clinical manag...
Background Identification of patients at risk of deterioration is essential to guide clinical manage...
Pulmonary arterial hypertension is most often diagnosed in its advanced stages because of the nonspe...
textabstractObjectives: To provide a comprehensive overview of all reported cardiac magnetic resonan...
OBJECTIVES: To provide a comprehensive overview of all reported cardiac magnetic resonance (CMR) fin...
Abstract Objectives The aim of this study was to evaluate the relationships between echocardiographi...
Pulmonary arterial hypertension (PAH), defined as group 1 of the World Heart Organisation (WHO) clas...
Objectives This meta-analysis evaluates assessment of pulmonary arterial hypertension (PAH), with...
Objectives: This meta-analysis evaluates assessment of pulmonary arterial hypertension (PAH), with a...
Pulmonary arterial hypertension (PAH) is characterized by an insult in the pulmonary vasculature, wi...
BackgroundPulmonary arterial capacitance (PAC) is one of the strongest predictors of clinical outcom...
AbstractObjectivesThe aim of this study was to evaluate the relationships between echocardiographic ...
BACKGROUND: Registry data suggest that disease progression in pulmonary arterial hypertension (PAH) ...
Background: Although pulmonary arterial hypertension (PAH) is widely accepted as deadly, if not a ra...
Several echocardiographic indices1–11 have been proposed to be prognostically important in patients ...